| Glioblastoma multiforme: the latest diagnostics and treatment techniques A Czarnywojtek, M Borowska, K Dyrka, S Van Gool, N Sawicka-Gutaj, ... Pharmacology 108 (5), 423-431, 2023 | 49 | 2023 |
| The influence of growth hormone therapy on the cardiovascular system in Turner syndrome K Dyrka, N Rozkiewicz, M Obara-Moszynska, M Niedziela Journal of Pediatric Endocrinology and Metabolism 33 (11), 1363-1372, 2020 | 14 | 2020 |
| The influence of various endocrine disruptors on the reproductive system A Czarnywojtek, M Borowska, K Dyrka, J Moskal, J Kościński, ... Endokrynologia Polska 74 (3), 221-233, 2023 | 12 | 2023 |
| Pathophysiology and advances in the therapy of cardiomyopathy in patients with diabetes mellitus P Graczyk, A Dach, K Dyrka, A Pawlik International Journal of Molecular Sciences 25 (9), 5027, 2024 | 8 | 2024 |
| Endocrine abnormalities induced by the antiviral drugs and frequency of their occurrence K Dyrka, M Miedziaszczyk, E Szałek, K Łącka Pol Merkur Lekarski 48 (285), 209-214, 2020 | 4 | 2020 |
| Drugs used in viral diseases-their mechanism of action, selected adverse effects and safety during pregnancy and lactation. K Dyrka, M Miedziaszczyk, E Szałek, K Łącka Advances in Hygiene & Experimental Medicine/Postepy Higieny i Medycyny …, 2019 | 4 | 2019 |
| TEMOZOLOMIDE: A CYTOSTATIC DRUG THAT IS STILL IMPORTANT TODAY. A Czarnywojtek, K Dyrka, M Borowska, J KOŚCIŃSKI, J Moskal, ... Acta Poloniae Pharmaceutica 79 (6), 2022 | 3 | 2022 |
| A new hypothesis in the treatment of recurrent glioblastoma multiforme (GBM). Part 2: Is there an alternative therapy option in recurrent GM when all standard treatments have … A Czarnywojtek, P Gut, J Sowiński, M Ruchała, A Ferlito, K Dyrka Pol Merkur Lekarski 51 (4), 433-435, 2023 | 2 | 2023 |
| Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)? A Czarnywojtek, P Gut, K Dyrka, J Sowiński, N Sawicka-Gutaj, K Katulska, ... Endokrynologia Polska 75 (2), 130-139, 2024 | 1 | 2024 |
| A new hypothesis in the treatment of recurrent glioblastoma multiforme (GBM). PART 1: Introduction A Czarnywojtek, P Gut, M Borowska, K Dyrka, M Ruchała, A Ferlito Pol. Merkur. Lekarski 51, 430-432, 2023 | 1 | 2023 |
| Thyroid gland and direc ta cting antivirals (DAAs) used to treat chroni ch epatitis C. Is it a safe regimen K Dyrka, M Borowska, A Czarnywojtek Pol Merkur Lekarski 50 (300), 388-390, 2022 | 1 | 2022 |
| The influence of monoclonal antibodies for cancer treatment on the endocrine system. K Dyrka, D Witasik, A Czarnywojtek, K Łącka Advances in Hygiene & Experimental Medicine/Postepy Higieny i Medycyny …, 2021 | 1 | 2021 |
| Case Report: Efficacy and safety of recombinant growth hormone therapy in a girl with Loeys–Dietz syndrome K Dyrka, A Jamsheer, M Bartecki, W Bobkowski, M Pawelec-Wojtalik, ... Frontiers in Cardiovascular Medicine 11, 1377510, 2025 | | 2025 |
| Central Diabetes Insipidus in Children as a Diagnostic Challenge K Dyrka, L Dzialach, M Niedziela, K Jonczyk-Potoczna, K Derwich, ... Clinical Pediatrics 63 (8), 1044-1055, 2024 | | 2024 |
| Autoimmune thyroiditis: an update on treatment possibilities K Dyrka, M Obara-Moszyńska, M Niedziela Endokrynologia Polska 75 (5), 461-472, 2024 | | 2024 |
| Efficacy and safety of recombinant growth hormone therapy in a girl with a Loeys-Dietz syndrome K Dyrka, A Tomaszewska, J Balcerzak, Z Aniol, M Niedziela, ... HORMONE RESEARCH IN PAEDIATRICS 96, 528-528, 2023 | | 2023 |
| Central diabetes insipidus in children as a diagnostic challenge–analysis of different clinical pictures and review of the literature K Dyrka, L Dzialach, M Niedziela, K Jonczyk-Potoczna, K Derwich, ... | | 2022 |
| Central diabetes insipidus in children-analysis of the different clinical picture K Dyrka, L Dzialach, K Derwich, M Niedziela, M Obara-Moszynska HORMONE RESEARCH IN PAEDIATRICS 95 (SUPPL 2), 542-542, 2022 | | 2022 |
| Efficacy of recombinant growth hormone therapy in TRPS 1 syndrome coexisting with growth hormone deficiency K Dyrka, M Obara-Moszynska, M Niedziela HORMONE RESEARCH IN PAEDIATRICS 94 (SUPPL 1), 335-336, 2021 | | 2021 |
| Wpływ przeciwciał monoklonalnych stosowanych w leczeniu nowotworów na układ endokrynny K Dyrka, D Witasik, A Czarnywojtek, K Łącka Postępy Higieny i Medycyny Doświadczalnej 75, 317-327, 2021 | | 2021 |
Monika Obara-MoszyńskaDepartment of Pediatric Endocrinology and Rheumatology, Poznan University of Medical SciencesCorreu electrònic verificat a ump.edu.pl
